---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-009724"
form_type: "8-K"
ticker: "PVLA"
cik: "0001583648"
company_name: "PALVELLA THERAPEUTICS, INC."
filed_at: "2026-01-12T23:59:59+00:00"
generated_at: "2026-05-16T10:52:13.241467+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Palvella posts corporate presentation; no new disclosures

## Summary
- Corporate presentation posted on company website on January 12, 2026.
- Presentation title: "First-in-disease therapies for patients with rare diseases."
- Company will use the presentation in investor meetings; no financial or pipeline updates in the filing.

## SEC filing metadata
- accession: 0001193125-26-009724
- form_type: 8-K
- ticker: PVLA
- cik: 0001583648
- company_name: PALVELLA THERAPEUTICS, INC.
- filed_at: 2026-01-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583648/000119312526009724/0001193125-26-009724-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583648/000119312526009724/pvla-20260112.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-009724
- JSON: https://secwatch.observer/filing/0001193125-26-009724.json
- Plain text: https://secwatch.observer/filing/0001193125-26-009724.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.